Press Release

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Medical Cannabis Market to Grow at a CAGR of 12.3% between 2021-2026

According to a new report by EMR titled, ‘Global Medical Cannabis Market Report and Forecast 2021-2026’, the global medical cannabis market reached USD 7.8billion in 2020. The market is expected to grow further in the forecast period of 2021-2026 at a CAGR of 12.3%.

The global medical cannabis market is being driven by the rise in the legalisation of cannabis. North America is the largest market for marijuana, for both medical and recreational uses. The regional market is being aided by the high population density of the areas with legalised medical cannabis as more than 60% of the region’s population reside in these areas. In 2017, nearly 1.9 million people in North America were legally utilising the substance to relieve conditions like chronic pain and polymorphic seizures. In Canada, while the consumption of cannabis for medical purposes has been legal since 2001, in October 2018, the country legalised the substance for recreational use too. Health Canada governs the Canadian medical cannabis industry, and as of September 2017, had 58 licensed cannabis producers, with 167, 754 registered patients in March 2017 using cannabis. Medical marijuana is expected to contribute to nearly 25% of cannabis sales in 2020. Canada is a leading cannabis market, globally, and exports the substance to other major overseas markets like Western Europe.

Get a Free Sample Report With TOC For Market Study - Download Now

The US is also a major global market and is finding impetus for its growth in the increasing legalisation of the substance. Currently, the use of medical marijuana is legal in 33 states and Washington, D.C. The retail sales of medicinal marijuana in the country reached nearly USD 3.7 billion in 2018. While individual states are passing laws legalising cannabis, it is still illegal under federal law. Thus, multiple US companies prefer conducting their research on medical marijuana in countries like Israel, where they are not hindered by federal institutes like the National Institute on Drug Abuse and the Drug Enforcement Agency. Israel is one of the leading regions for cannabis research, and over 50 US companies are undertaking research related to medical cannabis in the country.

Market Breakup by Types, Species, Compounds, Applications, Distribution Channels, and Region:

  • Medical cannabis can be bifurcated into dried form and extract form. 
  • It can be divided into Indica, Sativa, and hybrid species. 
  • It is available as compounds like THC- dominant, CBD-dominant, and balanced THC and CBD. 
  • Pain management and seizures, among others, are the leading applications for medical cannabis. 
  • Dispensaries, pharmacies, and online retailers are the major distribution channels for medical marijuana. 
  • By region, the market can be divided into North America, Europe, Asia Pacific, LATAM, and the Middle East and Africa.

Key Findings of the Report:

  • The global medical cannabis market is being driven by the rising legalisation of cannabis as consumers are willing to spend more on legal cannabis products.
  • Medical cannabis is a major growth sector for pharmaceutical industry, globally.
  • The rise in the geriatrics population who are more likely to suffer from chronic illnesses and pains is further aiding the market. 
  • The growth in consumer awareness along with the increase in disposable incomes, is driving the industry growth. 
  • Medical cannabis is being preferred over opioid-based medications as they are perceived as being safer.

Key Offerings of the Report:

  • The EMR report gives a detailed insight into the types, species, compounds, applications, distribution channels, and regional markets of medical cannabis for the periods (2016-2020) and (2021-2026). 
  • It gives an analysis of the global trade data for the year 2020. 
  • The report by EMR provides the regional historical (2016-2020) and forecasted (2021-2026) price trends of medical cannabis.

Tilray, Bedrocan International, Canopy Growth Corporation, Aurora Cannabis Inc., Vivo Cannabis Inc., Maricann Inc., Medical Marijuana Inc., Organigram Holdings Inc., The Scotts Company LLC, and Curaleaf Holdings, Inc., among others are the major players in the global medical cannabis market. The comprehensive report looks into their capacity, market share, and latest developments like merger and acquisitions, capacity expansions, and plant turnarounds.

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.